Dimopoulos, M Trotman, J Tedeschi, A Matous, J Macdonald, D Tam, C Tournilhac, O Ma, S Oriol, A Heffner, L others, Efficacy and safety of single-agent ibrutinib in rituximab-refractory patients with Waldenström’s macroglobulinemia (WM): Initial results from an international, multicenter, open-label phase 3 substudy (iNNOVATETM): 195, British Journal of Haematology, (173), 2016, 0007-1048, 1365-2141